Statistics for PRKAR1B-AS2 Long Noncoding RNA Promotes Tumorigenesis, Survival, and Chemoresistance via the PI3K/AKT/mTOR Pathway
Total visits
| views | |
|---|---|
| PRKAR1B-AS2 Long Noncoding RNA Promotes Tumorigenesis, Survival, and Chemoresistance via the PI3K/AKT/mTOR Pathway | 70 |
Total visits per month
| views | |
|---|---|
| January 2024 | 0 |
| February 2024 | 0 |
| March 2024 | 0 |
| April 2024 | 0 |
| May 2024 | 0 |
| June 2024 | 0 |
| July 2024 | 0 |
File Visits
| views | |
|---|---|
| ijms-22-01882.pdf | 35 |
Top country views
| views | |
|---|---|
| United States | 57 |
| Bulgaria | 2 |
| China | 1 |
| United Kingdom | 1 |
| Malaysia | 1 |
| Sweden | 1 |
Top city views
| views | |
|---|---|
| Wilmington | 40 |
| Houston | 5 |
| Fairfield | 4 |
| Cambridge | 2 |
| Sofia | 2 |
| Ann Arbor | 1 |
| Lake Mary | 1 |
| Seremban | 1 |
| Warrington | 1 |